Pharmafile Logo

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400

 Latest Content from PMHub 

North – Corporate Animation

We partnered with 'North' to create a fun and vibrant launch animation. North are a business consultancy that bring fresh perspectives to running a business and they wanted their brand...

Cholangiocarcinoma – Disease Awareness

BackgroundCholangiocarcinoma (CCA) is a rare type of bile duct cancer, and it’s the second most common primary liver cancer in the world. Unfortunately, patients with CCA historically have limited treatment...

Health content that resonates

Videos and Podcasts | November 7, 2022 | Thrive Agency

Here at Thrive, our purpose is to help everyone to better health through content that informs and empowers them.Since 2001 our researchers, writers, medical and behavioural experts have been on...

How Pharma, Payers, & Providers are Leveraging Patient Self-Management Platforms

Rick Anderson, President of DarioHealth, explores digital therapeutics, how DarioHealth is utilizing AI and behavioral science to personalize each user’s health journey, and how this approach can help improve diversity...

The fast-paced future of cell and gene therapies

In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist...

Personalized Oncology: Calling for a New Kind of Partnership:

White Papers and Resources | October 28, 2022 | Inizio

In the 1990s, biomarkers were the future of personalized medicine and a “lab on a chip” was the holy grail of understanding patient health. As much as past predictions of...

Expanding Opportunities for Healthcare with “Digital Twins”

Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve...